Target- |
MechanismImmunostimulants |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 2001 |
100 Clinical Results associated with Harbin Changxinxin Pharmaceutical Research Institute
0 Patents (Medical) associated with Harbin Changxinxin Pharmaceutical Research Institute
100 Deals associated with Harbin Changxinxin Pharmaceutical Research Institute
100 Translational Medicine associated with Harbin Changxinxin Pharmaceutical Research Institute